Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
NRG Oncology
NRG Oncology
Georgetown University
Chiayi Christian Hospital
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
German University in Cairo
Instituto Nacional de Cancer, Brazil
University of Aarhus
Mansoura University
EpicentRx, Inc.
First Affiliated Hospital of Guangxi Medical University
Universidad del Desarrollo
Sun Yat-sen University
Federal University of Rio Grande do Sul
West China Hospital